Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ST-1898 in Advanced Renal Cell Carcinoma
NCT06127238Phase 2Active, not recruiting
- Sponsor
- Beijing Scitech-MQ Pharmaceuticals Limited
- Start
- Feb 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ACC-1898 in renal cell carcinoma (RCC), sponsored by Beijing Scitech-MQ Pharmaceuticals Limited. Started Feb 2023; status: active, not recruiting.
02
Drugs
ACC-1898
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT06127238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06127238.